• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Rep, AMRO, DBM, NAE













On another note, does anyone know the name of a retired dbm in south Florida. His first name was Al. Bald guy, know for being incredibly tough on his team. I was told he was a former military interrogator.
 




How does a dork in Texas go from rep to AMFO to DBM to NAE in less than 6 years? Not a leader, terrible stories told about him and another member of the leadership team, I just don’t get it. Oh, yeah, no oncology sales experience when he came. Totally baffling.